Loading…
Alliqua BioMedical announced a definitive agreement for Celularity to acquire its advanced biologic wound care business and therapeutic ultrasound platform products for $29 million in cash. The transaction is subject to stockholder approval.
Argentum Medical, LLC, an advanced wound care platform of Shore Capital Partners, acquired the TheraBond family of products from Alliqua BioMedical, Inc. The products include contact dressings, island dressings and wraps for burn care and wound care.